The Enterprise Value as of December 2025 (TTM) for Excelsior Biopharma Inc. (6496.TWO) is 1.62B

According to Excelsior Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.62B. This represents a change of 8.28% compared to the average of 1.49B of the last 4 quarters.

Excelsior Biopharma Inc. (6496.TWO) Historical Enterprise Value (quarterly & annually)

How has 6496.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Excelsior Biopharma Inc. over the last ten years is 798.93M. The current 1.62B Enterprise Value has changed 20.16% with respect to the historical average. Over the past ten years (40 quarters), 6496.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 1.67B. The Enterprise Value was at its lowest in in the September 2023 quarter at 758.94M.

Excelsior Biopharma Inc. (6496.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Excelsior Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Excelsior Biopharma Inc. (6496.TWO) Average Enterprise Value

How has 6496.TWO Enterprise Value performed in the past?

The current Enterprise Value of Excelsior Biopharma Inc. (6496.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Excelsior Biopharma Inc. (6496.TWO) Enterprise Value vs. Peers

How is 6496.TWO’s Enterprise Value compared to its peers?

Excelsior Biopharma Inc.’s Enterprise Value is greater than Anxo Pharmaceutical Co., Ltd. (1.61B), greater than Kim Forest Enterprise Co., Ltd. (1.42B), greater than Holy Stone Healthcare Co., Ltd. (1.10B), greater than GeneReach Biotechnology Corp. (1.26B), greater than Unicon Optical Co., Ltd. (1.27B), greater than DV Biomed Co., Ltd. (1.08B), greater than MegaPro Biomedical Co., Ltd (935.80M), less than Tien Liang BioTech Co., Ltd. (1.76B), greater than Prince Pharmaceutical Co., Ltd. (1.48B), greater than Great Novel Therapeutics Biotech & Medicals (1.29B),

Build a custom stock screener for Excelsior Biopharma Inc. (6496.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Excelsior Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Excelsior Biopharma Inc. (6496.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Excelsior Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.